In addition, the implication of Th17 cells and the production of IL-17 has been reported in multiple studies both in patients and mice [159,160,161], and its pathogenic role has been proved by inhibition of IL-17A/IL-17AR signaling, which protected mice from diet-induced liver steatosis and liver injury [160,162]. This evidence concerns the gene IL17A and fatty liver disease.